Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 6;11(2):470.
doi: 10.3390/biomedicines11020470.

Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes

Lee-Moay Lim  1   2   3 , Jer-Ming Chang  2   3 , Hung-Tien Kuo  2   3
Affiliations
Review

Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes

Lee-Moay Lim et al. Biomedicines. .

Abstract

Kidney transplant recipients are a unique subgroup of chronic kidney disease patients due to their single functioning kidney, immunosuppressive agent usage, and long-term complications related to transplantation. Post-transplant diabetes mellitus (PTDM) has a significant adverse effect on renal outcomes in particular. As transplantations enable people to live longer, cardiovascular morbidity and mortality become more prevalent, and PTDM is a key risk factor for these complications. Although PTDM results from similar risk factors to those of type 2 diabetes, the conditions differ in their pathophysiology and clinical features. Transplantation itself is a risk factor for diabetes due to chronic exposure to immunosuppressive agents. Considering current evidence, this article describes the risk factors, pathogenesis, diagnostic criteria, prevention strategies, and management of PTDM. The therapeutic options are discussed regarding their safety and potential drug-drug interactions with immunosuppressive agents.

Keywords: diabetic kidney disease; kidney transplantation; post-transplant diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Inter-relations of Rejection, Immunosuppression, and Diabetes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Carminatti M., Tedesco-Silva H., Silva Fernandes N.M., Sanders-Pinheiro H. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors. Nephrology. 2019;24:141–147. doi: 10.1111/nep.13483. - DOI - PubMed
    1. Au E., Wong G., Chapman J.R. Cancer in kidney transplant recipients. Nat. Rev. Nephrol. 2018;14:508–520. doi: 10.1038/s41581-018-0022-6. - DOI - PubMed
    1. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: A critical reappraisal. Am. J. Transpl. 2011;11:450–462. doi: 10.1111/j.1600-6143.2010.03283.x. - DOI - PubMed
    1. Moroni G., Binda V., Quaglini S., Sacchi L., Raffiotta F., Cosa F., Montagnino G., Favi E., Messa P., Ponticelli C. Causes of late transplant failure in cyclosporine-treated kidney allograft recipients. Clin. Exp. Nephrol. 2019;23:1076–1086. doi: 10.1007/s10157-019-01740-7. - DOI - PubMed
    1. Ponticelli C., Favi E., Ferraresso M. New-Onset Diabetes after Kidney Transplantation. Medicina. 2021;57:250. doi: 10.3390/medicina57030250. - DOI - PMC - PubMed